Microbix Partners with NCIPD for Pathogen Seedstock Supply
Microbix and NCIPD Forge Strategic Agreement
Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF), a prominent life sciences innovator and manufacturer, has recently announced a significant agreement with the National Center for Infectious and Parasitic Diseases of Bulgaria (NCIPD). This multi-year collaboration focuses on the exclusive supply of pathogen seedstocks, which are pivotal in producing Microbix's quality assessment products (QAPs™). This strategic move aims to enhance diagnostic testing accuracy and quality globally.
Details of the Collaboration
The agreement derived from extensive discussions held at NCIPD’s headquarters, bringing together leaders from both organizations. This partnership will see NCIPD provide various organisms to Microbix in exchange for a combination of license fees, material-transfer fees, and royalties based on net sales from related QAPs. Such a collaboration is vital as it promises to keep enhancing the quality of tests utilized for diagnosing infectious diseases.
About the Pathogen Seedstocks and QAPs
The pathogen seedstocks supplied by NCIPD will play a crucial role in the development of several new QAPs. These QAPs serve as test controls, acting as inactivated mimetics of actual patient samples. By validating tests, they support greater accuracy in diagnosing diseases, thereby directly influencing human health and well-being worldwide. Microbix has been recognized for its commitment to producing reliable QAPs that help validate diagnostic workflows in laboratories.
Legacy and Expertise of NCIPD
Founded in 1881, the NCIPD has long been a pioneer in combating infectious and parasitic diseases. It remains a national institution under the Ministry of Health, maintaining all National Reference Laboratories while playing a vital role in postgraduate training in numerous medical fields. The institute has been acknowledged by the European Center for Disease Control (ECDC) for its expertise, further solidifying its vital role in infectious disease research.
Microbix's Contributions to Global Health
Microbix has established itself as a leader in the production of biological ingredients over the past 40 years. The company excels in the creation of QAPs, boasting a current lineup of around 300 QAPs focusing on infectious diseases. This new partnership with NCIPD is expected to significantly expand their offerings, illustrating Microbix's dedication to advancing global health standards.
Comments from Leadership
Professor Dr. Iva Christova, Director of NCIPD, expressed enthusiasm for the new partnership, emphasizing the importance of international collaboration in ensuring the accuracy of diagnostic tests. Her sentiments were echoed by Pavel Zhelev, Director of Product Management at Microbix, who highlighted the mutual benefits arising from this partnership, particularly its potential in fostering innovation in QAP development.
Contact Information for Inquiries
For further inquiries regarding Microbix QAPs, contact can be made via email at customer.service@microbix.com. For questions related to NCIPD or its operations, reach out at director@ncipd.org.
About Microbix Biosystems Inc.
Microbix Biosystems Inc. specializes in creating proprietary biological products aimed to boost human health. Employing over 120 skilled professionals, the company is driving towards monthly sales of C$ 2 million or more. Their portfolio includes critical ingredients and devices tailored for the global diagnostics sector. With products available in over 30 countries, Microbix remains an ISO 9001 & 13485 accredited entity, ensuring a high standard of quality in all offerings.
Frequently Asked Questions
What is the recent partnership between Microbix and NCIPD aimed at?
The partnership focuses on supplying pathogen seedstocks to enhance the production of Microbix's quality assessment products (QAPs™).
How will this agreement impact diagnostic testing?
This collaboration is expected to improve the accuracy and quality of tests used in diagnosing infectious diseases.
What is the historical significance of NCIPD?
NCIPD has been a leading institution since 1881, specializing in tackling contagious and parasitic diseases on national and international levels.
How many QAPs does Microbix currently offer?
Microbix currently offers approximately 300 QAPs designed specifically for supporting infectious disease diagnostics.
How can I contact Microbix or NCIPD for more information?
You can email Microbix at customer.service@microbix.com or contact NCIPD through director@ncipd.org.
About The Author
Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.